Upgrade to SI Premium - Free Trial

Sunshine Biopharma, Inc. (SBFM)

0.22 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/10/26)

Latest Headlines

Form PRE 14C Sunshine Biopharma Inc. For: Oct 14 October 14, 2026 5:21 PM - SEC Filing Form 8-K Sunshine Biopharma Inc. For: Oct 13 October 14, 2026 4:05 PM - SEC Filing Form SCHEDULE 13G Sunshine Biopharma Inc. Filed by: BJI Financial Group October 14, 2026 10:42 AM - SEC Filing Form SCHEDULE 13G Sunshine Biopharma Inc. Filed by: CVI Investments, Inc. October 13, 2026 4:21 PM - SEC Filing Form 8-K Sunshine Biopharma Inc. For: Oct 08 October 9, 2026 5:25 PM - SEC Filing Form 424B4 Sunshine Biopharma Inc. October 9, 2026 5:25 PM - SEC Filing Sunshine Biopharma closes $6M public offering with warrant upside October 9, 2026 11:17 AM - StreetInsider Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering October 9, 2026 11:17 AM - StreetInsider Form EFFECT Sunshine Biopharma Inc. October 8, 2026 6:04 AM - SEC Filing Form SCHEDULE 13G/A Sunshine Biopharma Inc. Filed by: Alta Partners LLC October 5, 2026 4:07 PM - SEC Filing Form S-1 Sunshine Biopharma Inc. October 2, 2026 4:50 PM - SEC Filing Form DEF 14C Sunshine Biopharma Inc. For: Sep 15 September 28, 2026 6:05 AM - SEC Filing Sunshine Biopharma launches generic Zofran in Canada September 24, 2026 9:02 AM - StreetInsider Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio September 24, 2026 9:01 AM - StreetInsider Form PRE 14C Sunshine Biopharma Inc. For: Sep 15 September 16, 2026 4:10 PM - SEC Filing Form 8-K Sunshine Biopharma Inc. For: Sep 15 September 16, 2026 4:06 PM - SEC Filing Sunshine Biopharma moves coronavirus drug candidate into IND studies September 16, 2026 9:01 AM - StreetInsider Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies September 16, 2026 9:00 AM - StreetInsider Form 8-K Sunshine Biopharma Inc. For: Sep 11 September 11, 2026 5:00 PM - SEC Filing Health Canada approves Sunshine Biopharma's generic Atenolol tablets August 31, 2026 9:02 AM - StreetInsider Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions August 31, 2026 9:01 AM - StreetInsider Form S-1 Sunshine Biopharma Inc. August 28, 2026 4:16 PM - SEC Filing Form 8-K Sunshine Biopharma Inc. For: Aug 25 August 28, 2026 4:06 PM - SEC Filing A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity August 26, 2026 9:20 AM - StreetInsider Sunshine Biopharma reports tumor suppression results with K1.1 mRNA program August 26, 2026 9:02 AM - StreetInsider Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer August 26, 2026 9:01 AM - StreetInsider Sunshine Biopharma gets Canadian approval for generic Enalapril August 19, 2026 9:02 AM - StreetInsider Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market August 19, 2026 9:01 AM - StreetInsider Form SCHEDULE 13G/A Sunshine Biopharma Inc. Filed by: L1 Capital Global Opportunities Master Fund, Ltd. August 14, 2026 4:16 PM - SEC Filing Form 10-Q Sunshine Biopharma Inc. For: Jun 30 August 13, 2026 4:08 PM - SEC Filing Form SCHEDULE 13G/A Sunshine Biopharma Inc. Filed by: INTRACOASTAL CAPITAL, LLC August 13, 2026 10:21 AM - SEC Filing Form 4 Sunshine Biopharma Inc. For: Aug 07 Filed by: NATAN DAVID August 11, 2026 4:23 PM - SEC Filing Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market August 7, 2026 9:01 AM - StreetInsider Sunshine Biopharma gets Canadian approval for generic Dienogest tablets August 4, 2026 9:02 AM - StreetInsider Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval August 4, 2026 9:01 AM - StreetInsider Form 8-K Sunshine Biopharma Inc. For: Aug 03 August 3, 2026 8:52 AM - SEC Filing Health Canada approves Sunshine Biopharma's generic Ondansetron July 28, 2026 8:04 AM - StreetInsider Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting July 28, 2026 8:01 AM - StreetInsider Full Article List